Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-059774
Filing Date
2025-04-29
Accepted
2025-04-29 12:46:45
Documents
2
Period of Report
2025-04-28

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1543
2 EX-24.1 hrtx-ex24_1.htm EX-24.1 23056
  Complete submission text file 0000950170-25-059774.txt   26260
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O HERON THERAPEUTICS, INC. 100 REGENCY FOREST DRIVE, SUITE 300 CARY NC 27518
Business Address
Hensley Mark Earl (Reporting) CIK: 0002065816 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33221 | Film No.: 25884933